We have located links that may give you full text access.
Diagnosis of small vestibular schwannomas using constructive interference steady state sequence.
Laryngoscope 2018 September
OBJECTIVES/HYPOTHESIS: The objectives of this study were to evaluate the diagnostic accuracy of constructive interference steady state (CISS) sequencing compared to gadolinium-enhanced T1 (GdT1) magnetic resonance imaging (MRI) to screen for small vestibular schwannomas (VSs), and to assess the overall diagnostic confidence of neuroradiologists in their ability to accurately diagnose or rule out VSs using CISS imaging compared to a GdT1 MRI STUDY DESIGN: Retrospective chart review.
METHODS: Chart review from 2011 to 2015 was performed for VS/benign cerebellopontine angle tumors. Two blinded, board-certified neuroradiologists each independently reviewed the axial CISS sequence and answered a set of questions that determined their confidence in diagnosis of VS. Next, each neuroradiologist independently reviewed the corresponding GdT1 MRI sequence and completed the same questionnaire.
RESULTS: The majority of the lesions were in the lateral internal auditory canal, with eight intralabyrinthine tumors. The overall sensitivity of CISS for both readers was 93.5%. All tumor locations had high sensitivities except for the intralabyrinthine location (62.3%). Four of the eight total intralabyrinthine lesions were missed by at least one reader. Each reader was highly confident in diagnosing VSs with CISS, which approximated that of GdT1 MRI.
CONCLUSIONS: This study's results showed that CISS examinations for screening of small VS approximated that of GdT1. Neuroradiologists had high sensitivity, perfect specificity, and felt confident in ruling out a VS on CISS sequence while feeling extremely confident in diagnosing one on CISS. Intralabyrinthine lesions and lesions ≤3.0 mm are most at risk for not being detected on CISS examinations.
LEVEL OF EVIDENCE: 4 Laryngoscope, 128:2128-2132, 2018.
METHODS: Chart review from 2011 to 2015 was performed for VS/benign cerebellopontine angle tumors. Two blinded, board-certified neuroradiologists each independently reviewed the axial CISS sequence and answered a set of questions that determined their confidence in diagnosis of VS. Next, each neuroradiologist independently reviewed the corresponding GdT1 MRI sequence and completed the same questionnaire.
RESULTS: The majority of the lesions were in the lateral internal auditory canal, with eight intralabyrinthine tumors. The overall sensitivity of CISS for both readers was 93.5%. All tumor locations had high sensitivities except for the intralabyrinthine location (62.3%). Four of the eight total intralabyrinthine lesions were missed by at least one reader. Each reader was highly confident in diagnosing VSs with CISS, which approximated that of GdT1 MRI.
CONCLUSIONS: This study's results showed that CISS examinations for screening of small VS approximated that of GdT1. Neuroradiologists had high sensitivity, perfect specificity, and felt confident in ruling out a VS on CISS sequence while feeling extremely confident in diagnosing one on CISS. Intralabyrinthine lesions and lesions ≤3.0 mm are most at risk for not being detected on CISS examinations.
LEVEL OF EVIDENCE: 4 Laryngoscope, 128:2128-2132, 2018.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app